Tuesday, March 3, 2009

Clinical Study Evaluates MORAb-009 Plus Standard Of Care For Extending Survival Of Patients With Mesothelioma

Morphotek®, Inc., a subsidiary of Eisai Corporation of North America, has announced that it has commenced a multi-centered Phase II study of its MORAb-009 monoclonal antibody in mesothelioma. The study will evaluate MORAb-009, plus the chemotherapy drugs pemetrexed and cisplatinum, as a first-line treatment for patients with mesothelioma. Continue reading ...

Self-Digestion As A Means Of Survival

In times of starvation, cells tighten their belts: they start to digest their own proteins and cellular organs. The process - known as autophagy - takes place in special organelles called autophagosomes. It is a strategy that simple yeast cells have developed as a means of survival when times get tough, and in the course of evolution, it has become a kind of self-cleaning process. More at...

Monday, March 2, 2009

Alcohol Types And Socioeconomic Status Are Associated With Barrett's Esophagus Risk

Alcohol Types And Socioeconomic Status Are Associated With Barrett's Esophagus Risk
Additional study suggests drinking alcohol in early adulthood may increase reflux esophagitis risk Although the relationship between alcohol and esophageal squamous cell carcinoma is well established, studies investigating the association between alcohol intake and reflux esophagitis (RE), Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) have reported inconsistent findings.